BACKGROUND AND OBJECTIVES: Marijuana is often used by patients with peripheral nerve injuries for pain management, but its impact on nerve transfer surgery outcomes remains unexplored. METHODS: This retrospective cohort study reviewed the records of patients age 18 years and older who underwent radial-to-axillary or ulnar fascicle to biceps fascicle (Oberlin) nerve transfers at a single institution from 2014 to 2023. Data collected included demographics, surgical details, injury characteristics, marijuana use, and Medical Research Council strength scores from preoperative evaluations to 24 months after operation. Statistical analyses were performed using χ 2 tests and analysis of variance. RESULTS: Forty-nine patients' (67 surgeries, 42 males, mean age 43.3 ± 17.3 years) records were analyzed. Radial-to-axillary nerve transfer and Oberlin transfer were performed in 18 patients. Radial-to-axillary nerve transfer was performed in 38 patients, and Oberlin transfer was performed in 29 patients. No significant differences were found regarding marijuana use and achievement of functional strength at 6, 12, 18, or 24 months postoperatively. No significant associations were found controlling for the type of surgery. Patients showing notable improvement between 6- and 24-month intervals and the preoperative and 24-month intervals were significantly younger than those without improvement ( P = .03 and P = .001, respectively). Compared with patients who did not improve in functional strength, patients achieving functional strength by 24 months postoperatively had a shorter interval between injury and surgery (0.7 ± 0.3 years vs 1.7 ± 2.5 years, P = .01). CONCLUSION: In patients undergoing radial-to-axillary nerve transfer or Oberlin nerve transfer surgery, marijuana use did not influence functional strength outcomes. Improvement in functional strength was associated with younger age and shorter time between injury and surgery.
Background/Objectives: Distant metastasis to the infratemporal fossa (ITF) is rare and can mimic primary skull-base tumors. We systematically reviewed reported distant ITF metastases. Methods: Following PRISMA 2020 (PROSPERO CRD420261422546), PubMed, Scopus, and Web of Science were searched through 12 June 2026, for reports of ITF metastasis from a distant primary tumor; direct extension from adjacent tumors was excluded. Data were summarized descriptively, and reports were appraised with the JBI Critical Appraisal Checklist for Case Reports. Results: Seventeen reports (17 patients) were included (median age 59 years). The lung was the most frequent primary site (n = 4), followed by the kidney, colorectum, and thyroid (n = 3 each); adenocarcinoma was the most common histology (n = 7). Facial pain (n = 9) and numbness (n = 6) predominated. Bone destruction was reported in 12 patients, and the maxillary sinus (n = 7), orbit (n = 6), pterygopalatine fossa (n = 5), middle cranial fossa (n = 5), and cavernous sinus (n = 4) were involved. The median reported interval to ITF metastasis was 36 months; 11 metastases were metachronous, and 11 patients had other metastatic disease during the reported course. Five patients underwent regional resection or debulking; radiotherapy was reported in eight, radioiodine in three, and systemic drug treatment in nine. At last follow-up, 11 patients were alive, four had died, and status was unknown in two. Conclusions: Distant ITF metastases may present with facial pain and cranial neuropathies. Prognosis is insufficiently characterized, and management should be individualized within a multidisciplinary team. The evidence is limited to case reports with incomplete reporting. No external funding was received.
18 June 2026 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Cavum septum pellucidum (CSP), cavum vergae (CV), cavum veli interpositi (CVI), and interthalamic adhesion (IA) are midline developmental variants and their associations with psychiatric disorders are unclear. Our study aimed to compare the prevalence of these four structures and the dimensional features of CSP in bipolar disorder (BD), major depression (MD), and obsessive-compulsive disorder (OCD) with healthy controls (HC) under a single MRI protocol. A total of 454 adults with 1.5T brain MRI were examined retrospectively. CSP length ≤6 mm was classified as “small,” >6 mm as “large”; the presence of CV, CVI, and IA was evaluated by two blinded radiologists. When all participants (patients and healthy controls) were considered together, CSP prevalence was 61.5%. “Large” CSP was observed only in clinical groups (BD 23.8%; MD 38.1%; OCD 38.1%). CVI was found in 37.4% of OCD and 29.9% of MD patients, showing a significant increase compared to 10.5% in HC (p